Comprehensive Bladder Management Program Combined with a Biofeedback Stimulator in Neurogenic Bladder Rehabilitation

Neurogenic Bladder (NB) refers to the dysfunction of the urinary tract caused by damage to the central nervous system or peripheral nerves that control urination. The combination of Comprehensive Bladder Management (CBM) and biofeedback stimulator is one of the rehabilitation treatments to improve the quality of life and increase the quality of urination for patients with neurogenic bladder. Both aim to enhance the patient's bladder capacity, reduce residual urine volume, and decrease the incidence of urinary incontinence. However, there is no consensus on the therapeutic effect of comprehensive bladder management combined with biofeedback stimulators for patients with neurogenic bladder. This study aims to investigate the safety and effectiveness of bladder comprehensive management combined with a biofeedback stimulator for rehabilitation treatment in patients with neurogenic bladder. In this study, the experimental group underwent a step-by-step implementation of bladder comprehensive management combined with biofeedback stimulator therapy. The treatment was evaluated based on changes in bladder capacity, incidence of urinary incontinence, residual urine volume, and the responses on the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF). The results showed significant improvements in all parameters for both groups, with the treatment group achieving superior outcomes. Bladder capacity increased (212.37 ± 45.56 mL to 350.98 ± 93.52 mL), urinary incontinence incidence decreased (46.43% to 7.14%), residual urine volume reduced (149.25 ± 12.25 mL to 49.63 ± 6.96 mL), and ICIQ-SF scores improved (14.12 ± 3.55 to 5.95 ± 2.26). These findings highlight the combined therapy's effectiveness in improving bladder function and reducing incontinence.